home All News open_in_new Full Article
Biosidus Announces Promising Interim Results from Phase III Study on Agalsidase Beta for Fabry Disease
today 5 d. ago attach_file Other
attach_file
Culture
attach_file
Politics
attach_file
Economics
attach_file
Sport
attach_file
Economics
attach_file
Culture
attach_file
Economics
attach_file
Economics
attach_file
Economics
attach_file
Economics
attach_file
Economics
attach_file
Economics
attach_file
Economics
attach_file
Economics
attach_file
Other
attach_file
Other
ID: 2185702215